biotechnology
Custom-Made Molecules
Custom-Made Molecules
Ruth Williams | Aug 21, 2017
A new prototype machine can make the biological molecules of one’s choice from digital DNA sequences.
Thermo Fisher to Buy Patheon for $5.2 Billion
Thermo Fisher to Buy Patheon for $5.2 Billion
Aggie Mika | May 16, 2017
The scientific supply giant seeks to expand into biopharma development and manufacturing.  
Former Head of Genzyme Dies
Former Head of Genzyme Dies
Diana Kwon | May 15, 2017
Henri Termeer helped usher the biotech company into an industry behemoth.
Mini Female Reproductive System on a Chip
Mini Female Reproductive System on a Chip
Diana Kwon | Mar 28, 2017
Scientists create an organ-on-a-chip system that can simulate the human menstrual cycle. 
Image of the Day: Electronic Beats
Image of the Day: Electronic Beats
The Scientist Staff | Feb 26, 2017
Scientists create an artificial heart fiber that can mimic the movement in a living heart.
Broad Wins CRISPR Patent Interference Case
Broad Wins CRISPR Patent Interference Case
Jef Akst | Feb 15, 2017
The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.
Opinion: Preparing for Potential Disasters
Opinion: Preparing for Potential Disasters
Larissa Paschyn | Jan 25, 2017
How to increase the resiliency of biotechnology organizations in the face of emergency risks
Drug Approval Timeline Same as 20 Years Ago
Drug Approval Timeline Same as 20 Years Ago
Kerry Grens | Jan 9, 2017
A report finds that new medications still take about 12 years to go from patent to patient.
Monsanto and Bayer Announce Approval of Massive Merger
Monsanto and Bayer Announce Approval of Massive Merger
Bob Grant | Dec 13, 2016
On Tuesday, shareholders at the agribusiness giant approved the $66 billion deal with the European pharmaceutical firm.
Stem Cells Made Waves in Biology and Medicine
Stem Cells Made Waves in Biology and Medicine
Karen Zusi | Oct 1, 2016
Since their introduction to the lab, pluripotent stem cells have gone from research tool to therapeutic, but the journey has been rocky.